• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Scientific Session Call for Abstracts
      • 2026 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
  • Opportunities
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • OWLS/FLS
You are here: Home / Abstracts / The role of laparoscopic primary tumor removal for patients with stage IV colorectal cancer

The role of laparoscopic primary tumor removal for patients with stage IV colorectal cancer

Shinobu Ohnuma, MD, PhD, Hideaki Karasawa, MD, PhD, Kazuhiro Watanabe, MD, PhD, Akihiro Yamamura, MD, PhD, Hirofumi Imoto, MD, PhD, Atsushi Kohyama, MD, PhD, Takeshi Aoki, MD, PhD, Naoki Tanaka, MD, PhD, Hiroaki Musha, MD, PhD, Fuyuhiko Motoi, MD, PhD, Takashi Kamei, MD, PhD, Takeshi Naitoh, MD, PhD, Michiaki Unno, MD, PhD. Department of Surgery, Tohoku University Hospital

Introduction: The role of primary tumor removal in patients with stage IV colorectal cancer (CRC) is still controversial. We assessed the impact of primary tumor removal for patients with stage IV CRC, and evaluated the role of laparoscopic surgery for patients with stage IV CRC.

Materials & Methods: One hundred eighty-four patients (male: 105, female: 79, median age: 66 (26-91)) with stage IV CRC who had surgical treatments in Tohoku University Hospital from 2000 to 2017 were retrospectively analyzed. Survival analysis was conducted using Kaplan-Meier methods. The relationship between primary tumor removal and overall survival (OS) was evaluated by Cox-proportional hazards regression models with age, sex, CEA, primary tumor location, metastatic sites and number, metastasectomy, and receipt of systemic chemotherapy.

Results: Primary tumor was surgically removed in 147 (80%) patients (group A), however, palliative procedures, such as colostomy or bypass, were carried out in 37 (20%) patients (group B). Three and five-years survival rate were 49% and 25% for group A, 7% and 0% for group B, respectively (p<0.0001). Cox-proportional hazards regression models indicated that female (HR: 0.60, 95%CI: 0.41 – 0.89, p = 0.0096), primary tumor removal (HR: 0.32, 95%CI: 0.20 – 0.52, p<0.0001), and metastasectomy (HR: 0.26, 95%CI: 0.11 – 0.53, p<0.0001) were associated with improved survival with the patients with Stage IV CRC. In group A, primary tumor of 109 patients (74%) were removed with open-laparotomy (OPEN), on the other hand, that of 38 patients (26%) were laparoscopically removed (LAP). LAP group showed statistically shorter hospital-length of stay after surgery (11 vs 19 days, p<0.0001), and less blood-loss (38 vs 309 ml, p<0.0001). There was no difference in operative time between the two groups (LAP vs OPEN, 224 vs 214 ml, p=0.7535). Furthermore, LAP was associated with a longer survival compared to OPEN group; three and five-years survival rate: 62% and 40% vs 44% and 22%, respectively (p=0.0345).

Conclusion: Primary tumor removal may improve the outcome of patient with stage IV CRC. Less invasive laparoscopic approach may be beneficial for the patients with stage IV disease who need further immediate treatments for distant metastases.


Presented at the SAGES 2017 Annual Meeting in Houston, TX.

Abstract ID: 87645

Program Number: P286

Presentation Session: iPoster Session (Non CME)

Presentation Type: Poster

67

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Mastodon (Opens in new window) Mastodon
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on Bluesky (Opens in new window) Bluesky

Related


sages_adbutler_leaderboard

Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2025 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals